Drugs

Acrimony as angered ABPI axe astounded Astellas

John Pinching 24 June 2016

While the nation reels from its EU exit, Astellas UK has got its own worries to contend with. Today the company has been suspended, with immediate effect, from Association of the British Pharmaceutical Industry (ABPI) membership.

The suspension was enforced following a ‘serious matter’, which emerged during a PCMPA investigation into two complaints regarding the payment of clinicians to attend meetings in Europe.

Astellas UK and Astellas Europe had both been initially reported. The company has denied any deliberate wrongdoing.

Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.